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Purpose: The Barthel Index (BI)-100 is used to measure geriatric patients’ activities of daily 
living (ADL). The aim of this study was to explore whether BI at hospital admission is associ-
ated with mortality.
Patients and methods: In a nationwide population-based cohort study, patients aged ≥65 
years admitted during 2005–2014 to Danish geriatric departments were assessed with BI at 
admission. Data were entered into the Danish National Database of Geriatrics and linked at 
the individual level to the Danish health registers (Civil Registration System, National Patient 
Register, and National Database of Reimbursed Prescriptions). The BI was categorized into 
four predefined standard subcategories according to the national Danish version of the statisti-
cal classification of diseases (BI =80–100 [independent ADL], BI =50–79 [moderate reduced 
ADL], BI =25–49 [low ADL], and BI =0–24 [very low ADL]). Patients were followed until 
death, emigration, or end of the study (December 31, 2015). Associations with mortality 
adjusted for age, admission year, marital status, body mass index, Charlson comorbidity index, 
polypharmacy, and  hospitalizations during the preceding year were analyzed by multivariable 
Cox regression analysis.
Results: Totally, 74,603 patients were included. Women (63%) were older than men (mean 
[SD] age; 83 [7] vs 81 [7] years) and had higher BI (median [IQR]; 55 [30–77] vs 52 [26–77]). 
Median survival (years [95% CI]) was lowest in the subcategory “BI =0–24” in both women 
(1.3 [1.2–1.4]) and men (0.9 [0.8–0.9]). Adjusted mortalities (HR [95% CI]; reference BI 
=80–100) in women were 2.41 (2.31–2.51) for BI =0–24, 1.66 (1.60–1.73) for BI =25–49, and 
1.34 (1.29–1.39) for BI =50–79 and in men were 2.07 (1.97–2.18) for BI =0–24, 1.58 (1.51–1.66) 
for BI =25–49, and 1.29 (1.23–1.35) for BI =50–79.
Conclusion: BI at admission is strongly and independently associated with mortality in geriatric 
patients. BI has the potential to provide useful supplementary information for the planning of 
treatment and future care of older patients.
Keywords: ADL, prognostic, death, older, longitudinal
Introduction
The population of older people in the industrialized world is increasing due to the large 
birth cohorts born after World War II (WW2) in combination with a steady increase in 
life expectancy.1,2 There is an ongoing debate whether the increased life expectancy is 
adding bad or good years to life.3 National Danish data show that the gained years of 
life are largely years spent in good health,4 while years spent with severe limitations 
have not changed.4 In contrast, data from USA show that although average life expec-
tancy has increassed the time spent with disease and the loss in functional mobility has 
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increased over a 10-year period.4,5 Other data from USA show 
that the increased life expectancy has been associated with 
an increased disabled population in the final years of life.6–8 
Irrespective of the ongoing debate, the demographic change 
will lead to an increase in absolute numbers of older patients 
with chronic diseases, which will not diminish the need for 
hospital care. Yet, data from the WHO show that the number 
of hospital beds per 1,000 individuals in the Western world 
has decreased in the past 30 years.9 This inverse relationship 
has now become a challenge for the health care systems,1 
especially for older patients who find outpatient attendance 
and treatment more challenging.
Not only disability is increasing with aging but also both 
the number of morbidities and the proportion of people with 
multimorbidity increase substantially with age.10 In a new 
simulation model study, the number of older patients with 
complex multimorbidity is predicted to rise substantially 
over the next 20 years.11
Health care sectors are thus under pressure, and accurate 
prognostic instruments in hospital settings would be helpful 
to plan and optimize health care delivery for older people.12 
Several prognostic measurements already exist such as 
the multidimensional prognostic index (MPI).13 The latter 
includes clinical, functional, cognitive, nutritional, and social 
parameters and has been shown to have better prognostic 
accuracy in terms of mortality compared with other frailty 
scores.14 Other examples are the Hospital-patient One-year 
Mortality Risk (HOMR) score15 with an updated validated 
version “the HOMR-now! prognostic index”.16 However, MPI 
is time-consuming,17 and both “HOMR” and “HOMR-now!” 
fail to consider patients’ actual functioning level.15,16
A simple way to describe a person’s functional level is to 
evaluate activities of daily living (ADL).1 ADL characterize 
the capability of a person to do routine everyday activities, 
ranging from being very independent to being very dependent 
and requiring assistance. Therefore, an ADL assessment is a 
good proxy for a patient’s general health condition.
While both emerging disease and increasing disease 
severity may be difficult to identify in multimorbid and frail 
older patients, an increasing dependency in ADL is often rec-
ognized as an early warning sign of underlying disease in the 
geriatric patient. In a recent systematic review on prognostic 
indices for older hospitalized adults, most of the described 
indices indeed included different kinds of functional status 
assessments.18 ADL can be assessed using a score system 
like the Barthel Index (BI), which is a recognized and simple 
scoring instrument used to evaluate basic ADL functions, the 
level of physical performance, and the intensity of needed 
care.19–21 It is often noted as a gold standard outcome in terms 
of addressing ADL.22 In Denmark, BI is routinely assessed in 
geriatric patients at the time of hospital admission and data 
are collected in the Danish National Database of Geriatrics 
(NDG).23 Prior studies assessing older community-dwelling 
patients24,25 as well as smaller single-center studies on hos-
pitalized geriatric patients26,27 have reported associations 
with disability and mortality, but more generalizable data 
are lacking.
The aim of the present study was to examine whether 
nationwide routinely assessed BI in geriatric patients at 
hospital admission is associated with short- and long-term 
mortality.
Patients and methods
This study is a nationwide register-based longitudinal cohort 
study that combines data from four different Danish national 
registers: the Danish NDG,23 the Danish National Patient 
Register (NPR),28 the Danish Civil Registration System 
(CRS),29 and the Danish National Database of Reimbursed 
Prescriptions (NDRP).30
Data sources
The Danish CRS
The CRS has, since 1968, assigned a unique ten-digit civil 
personal registry (CPR) number to each Danish citizen at 
birth and to residents upon immigration.29 This enables 
accurate linkage of information at the individual level using 
many population-based national registers.31 Among others, 
the CRS holds data on death, migration, and marital status.
The Danish NDG
The NDG is a Danish national clinical quality database 
designed to include all patients aged >50 years admitted to 
a geriatric department in Denmark.23 Twenty-four geriatric 
departments exist in Denmark, and patients are admitted 
directly from the general practitioner, through the emergency 
department, or by transfer from other hospital departments. 
The nationwide database was established in 2005 and has 
shown stable completeness of 90%.23 The NDG contains 
information on a number of variables collected at the time 
of hospital admission, ie, height, weight, and assessment of 
ADL.
The Danish NPR
The NPR was established in 1977 and contains individual-
level information on all hospital admissions, discharge diag-
noses, and dates of admission and discharge.28 Emergency 
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department contacts and outpatient visits have been included 
since 1995.
The Danish NDRP
The NDRP is a prescription database that contains infor-
mation on redeemed prescriptions from all pharmacies in 
Denmark since 2004.30 Data are reported at the individual 
level. Only medications that are reimbursed are covered by 
the database.
study population
The study population was identified through the NDG23 and 
included all patients aged ≥65 years with their first registra-
tion in the NDG during the period from January 1, 2005, to 
December 31, 2014 (Figure 1).
Variables
Index date (index hospital admission date)
The index date was defined as the date of first registration 
of hospital admission in the NDG23 during the study period.
Mortality
The CPR number was retrieved from the NDG23 and linked 
to data from the CRS29 regarding the exact date of death.
Follow-up
Patients were followed from the index date until the time 
of death (outcome), emigration, or the end of the study on 
December 31, 2015, whichever occurred first, allowing for 
a maximum of 11 years of follow-up depending on the time 
of admission.
N=75,502                                                   
All patients aged ≥65 years with their
first registration in the Danish NDG during
the period 2005–2014
N=33
Patients with temporary civil person 
registration number
N=75,469
Patients
N=74,630
Patients
N=74,628
Patients
N=74,603
Final study population
N=839
Patients with double registration of manually
entered date of admission in the database
N=25
Patients emigrating before January 1, 2005
or dying before first registration of hospital
admission in the Database    
N=2
Patients with invalid civil person registration
number
Figure 1 Flowchart of the study population.
Abbreviation: nDg, national Database of geriatrics.
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BI-100
The BI was used to measure the patients’ level of dependency 
in ADL at the time of hospital admission.20,21,32 The NDG uses 
the modified BI version developed by Shah et al.32 The BI is a 
sum score across ten domains of ADL. Each domain is scored 
on a weighted numerical scale with lowest score indicat-
ing total dependency and highest score indicating complete 
independency: feeding (0–10 points), transfer (0–15 points), 
grooming (0–5 points), toilet use (0–10 points), bathing (0–5 
points), mobility (0–15 points), stair climbing (0–10 points), 
dressing (0–10 points), bowel function (0–10 points), and blad-
der function (0–10 points). Thus, the total score ranges from 0 
(completely dependent) to 100 (completely independent). The 
numerical BI was retrieved from the NDG23 and grouped into 
four standard diagnostic categories according to the national 
Danish version of the statistical classification of diseases:33 BI 
=80–100 (diagnose of chapter XVIII “Symptoms, signs and 
abnormal clinical laboratory findings, not elsewhere classified 
(R00-R99)” [DR] 670; independent ADL), BI =50–79 (DR671; 
moderate reduced ADL), BI =25–49 (DR672; low ADL), and 
BI =0–24 (DR673; very low ADL).27 The highest subcategory 
(BI =80–100) served as the reference category throughout 
analyses. At the time of hospital admission to geriatric depart-
ments, the BI is routinely scored by a geriatric nurse or a nursing 
assistant. Time for completion is approximately 5–10 minutes.19
Age
Patients were categorized in the following age group inter-
vals: 65–74, 75–84, 85–94, or ≥95 years.
Body mass index (BMI)
The BMI was calculated as the weight in kilograms divided 
by the height in meters squared retrieved from the NDG.23 
The BMI was divided into categories according to the WHO: 
BMI <18.5 (underweight), BMI 18.5–24.9 (normal weight), 
BMI 25–29.9 (overweight), or BMI ≥30 (obesity).
Marital status
Marital status at the index date was determined using data 
from the CRS29 and defined as unmarried, married, divorced, 
or widowed.
Charlson comorbidity index (CCI)
The CCI is a weighted index that reflects the prevalence of 
19 chronic diseases during a predefined time window and 
points are assigned according to the number and severity of 
disease.34 To take into account the burden of comorbidity, we 
calculated the CCI based on ICD-10 hospital discharge diag-
noses extracted from the NPR28 10 years prior to the index 
date. The CCI was calculated and categorized as 0, 1–2, or 
≥3 points with higher scores indicating increased morbidity.
Number of medications
The NDRP28 provided information about all redeemed pre-
scriptions for 3 years prior to the index date. The number of 
medications was defined as the number of different medica-
tions purchased in the 120 days prior to index date. Using a 
120-day cutoff as the observation window prior to the index 
date was chosen since most medications administered for 
long-term treatment in Denmark are dispensed in packages of 
around 100 pills.35 All redeemed prescriptions were included, 
except from the following Anatomical Therapeutic Chemical 
(ATC) codes: B05x (blood substitutes and perfusion solu-
tions), B06x (other hematological agents), D09x (medicated 
dressings), J07x (vaccines), N01x (anesthetics), and Vx (vari-
ous). Medications were counted at the fourth level of the ATC 
code, ie, including the first five digits of the ATC code (eg, 
salicylic acid and derivate ATC code: N02BA). Polypharmacy 
was defined as ≥5 redeemed prescriptions36 and excessive 
polypharmacy as ≥10 redeemed prescriptions.37,38 Patients 
were grouped into four categories according to the number 
of redeemed prescriptions: 0, 1–4, 5–9, or ≥10.
Prior hospital admission
The NPR28 was used to assess the number of hospitaliza-
tions (acute and elective) 1 year prior to the index date. 
Patients were grouped into three categories: 0, 1–2, or ≥3 
hospitalizations.
Period of index admission
Admission was grouped into two time periods: years 2005–
2009 and years 2010–2014.
statistical analyses
Data on variables were inspected graphically to identify 
normal or skewed data distribution. Descriptive statistics 
are reported as median with corresponding IQR (25–75% 
percentile) or mean with corresponding SD as appro-
priate. Tests of differences in the categorical variables 
were performed using the chi-squared test. Differences 
between groups in the numerical variables were tested, 
using the Wilcoxon rank-sum test (median differences) 
or the Student’s t-test (mean differences), as appropriate. 
Kaplan–Meier survival curves were calculated to exam-
ine crude survival proportions according to each of the 
four exposure subcategories of the BI. Univariable and 
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multivariable analyses were carried out using Cox regres-
sion and the multivariable analyses included adjustment 
for the following confounders: age, marital status, BMI, 
comorbidity, medication use, previous hospital admissions, 
and period of index admission. All variables were treated 
as categorical in the models. The statistical significance 
of the categorical variables included in the multivariable 
Cox regression model was tested using Wald statistics. The 
proportional hazard assumption was inspected graphically 
for the BI variable using a log–log plot and was found 
to be satisfactory. Patients with missing data on one or 
more of the included variables were excluded from the 
multivariable analyses, and thus the fully adjusted models 
were conducted as complete case analyses. For variables 
with a substantial amount of missing data, an additional 
descriptive nonresponse analysis was carried out to exam-
ine whether patients with missing vs non-missing data 
differed on selected variables. Imputation methods were 
not employed.39 All analyses were conducted separately 
for men and women to detect any gender differences in the 
associations. The statistical software STATA (StataCorp LP, 
College Station, TX, USA) was used to perform all analy-
ses, and a P-value of 0.05 indicated statistical significance.
Ethics
Informed consent was not necessary according to the Danish 
law on medical ethics due to the design using register-based 
data only. The Danish Data Protection Agency approved 
the study allowing linkage of data on an individual level 
(2012-58-0018, journal number 16/23359). Data are reported 
according to STROBE (Strengthening the Reporting of 
Observational studies in Epidemiology) guidelines.40
Results
Among all patients identified in the NDG (N=75,502), a 
total of 899 patients were excluded due to multiple registra-
tions or invalid information (Figure 1). Thus, the final study 
population at baseline consisted of 74,603 patients (46,823 
women [63%] and 27,780 men [37%]; Figure 1). The baseline 
characteristics of the final study population are summarized 
in Table 1. The age (mean [SD]) and the BI (median [IQR]) 
of the total cohort were 82 (7) years and 54 (29–77), respec-
tively. Compared with men, women were older (83 [7] years 
vs 81 [7] years), had a higher BI score (55 [30–77] vs 52 
[26–77]), were more often widowed (64.2% vs 31.8%), had 
less comorbidity (CCI ≥3 points; 29.5% vs 43.9%), and had 
higher prevalence of polypharmacy (≥5 medications; 65.8% 
vs 62.3%; Table 1).
A total of 69,968 (93.8%) patients (44,009 women and 
25,959 men) had complete data on BI at baseline. The distri-
bution of these patients (n [%]) in the four BI subcategories 
was for women, 9,970 (22.7%; BI =80–100), 14,683 (33.4%; 
BI =50–79), 10,375 (23.6%; BI =25–49), and 8,981 (20.4%; 
BI =0–24), and for men, 5,834 (22.5%; BI =80–100), 7,828 
(30.2%; BI =50–79), 6,105 (23.5%; BI =25–49), and 6,192 
(23.9%; BI =0–24). Sixty patients (31 women and 29 men) 
died on the same day at the index hospital admission and were 
therefore excluded from further analyses. Of these patients, 
only 15 women and 18 men had a BI reported. Thus, the total 
population with a BI score included in the further analyses 
was 69,935 patients (93.7%; 43,994 women and 25,941 men).
Follow-up ranged from 1 day to 10.98 years. A total of 
51,197 deaths occurred with no patients lost to follow-up. 
The median follow-up time after baseline was 2.23 years in 
women and 1.62 years in men, corresponding to a total of 
192,012 person-years.
Kaplan–Meier survival curves for the entire cohort 
are illustrated in Figure 2. Survival curves for the four BI 
subcategories showed higher mortality with decreasing BI 
subcategory (Figure 2). In each BI subcategory, the survival 
was greatest in women (univariable Cox regression with gen-
der as exposure and restriction to each BI subcategory). The 
median survival (years [95% CI]) for the four BI subcatego-
ries in women was 4.9 (4.7–5.0; BI =80–100), 3.5 (3.4–3.6; 
BI =50–79), 2.7 (2.6–2.8; BI =25–49), and 1.3 (1.2–1.4; 
BI =0–24), and in men was 3.6 (3.4–3.7; BI =80–100), 2.3 
(2.2–2.4; BI =50–79), 1.7 (1.6–1.8; BI =25–49), and 0.9 
(0.8–0.9; BI =0–24; Figure 2).
In univariable analyses, the risk of mortality (HR [95% 
CI]) increased with decreasing BI using subcategory “BI 
=80–100” as reference for women, 1.42 (1.38–1.47; BI 
=50–79), 1.76 (1.70–1.82; BI =25–49), and 2.72 (2.6–2.82; 
BI =0–24), and for men, 1.40 (1.35–1.46; BI =50–79), 1.73 
(1.66–1.81; BI =25–49), and 2.29 (2.19–2.39; BI =0–24; 
Table 2). The mortality also increased for both genders with 
increasing age, comorbidity, amounts of prescribed medica-
tions, and with increasing numbers of prior hospitalizations, 
whereas no difference was seen in the period of index admis-
sion (Table 2).
In multivariable analyses, lower BI scores remained asso-
ciated with higher mortality across gender (35,818 women 
and 20,754 men) using subcategory “BI =80–100” as the 
reference category and adjusting for age group, marital status, 
BMI, CCI, number of medications purchased in the 120 days 
prior to index date, number of hospital admissions during 1 
year before baseline, and year of index admission (Tables 
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Table 1 Baseline characteristics of the study population (n=74,603)
Women (n=46,823) Men (n=27,780)
Bi median (iQr)/mean (sD) 55 (30–77)/53 (29) 52 (26–77)/51 (30)
80–100, n (%) 9,970 (21.3) 5,834 (21.0)
50–79, n (%) 14,683 (31.4) 7,828 (28.2)
25–49, n (%) 10,375 (22.2) 6,105 (22.0)
0–24, n (%) 8,981 (19.2) 6,192 (22.3)
Missing, n (%) 2,814 (6.0) 1,821 (6.6)
age (years), median (iQr)/mean (sD) 84 (79–89)/83 (7) 81 (76–86)/81 (7)
65–74, n (%) 6,118 (13.1) 5,959 (21.5)
75–84, n (%) 18,365 (39.2) 12,246 (44.1)
85–94, n (%) 20,095 (42.9) 8,898 (32.0)
≥95, n (%) 2,245 (4.8) 677 (2.4)
Marital status, n (%)
Unmarried 2,733 (5.8) 2,118 (7.6)
Married 8,271 (17.7) 13,372 (48.1)
Divorced 5,765 (12.3) 3,444 (12.4)
Widowed 30,047 (64.2) 8,839 (31.8)
Missing 7 (0.0) 7 (0.0)
Period of admission
2005–2009 20,435 (43.6) 10,928 (39.3)
2010–2014 26,388 (56.4) 16,852 (60.7)
BMi (kg/m2), mean (sD) 23.6 (5.3) 24.5 (4.7)
<18.5, n (%) 5,448 (8.5) 1,642 (4.7)
18.5–24.9, n (%) 18,983 (40.5) 11,133 (40.1)
25–29.9, n (%) 8,660 (18.5) 6,401 (23.0)
≥30, n (%) 4,098 (8.8) 2,540 (9.1)
Missing, n (%) 9,634 (20.6) 6,064 (21.8)
CCi median (iQr)/mean (sD)a 2 (1–3)/2.0 (1.9) 2 (1–4)/2.6 (2.2)
0, n (%) 9,816 (21.0) 3,357 (12.1)
1–2, n (%) 23,178 (49.5) 12,234 (44.0)
≥3, n (%) 13,838 (29.5) 12,188 (43.9)
Missing, n (%) 1 (0.0) 0 (0.0)
number of drugs purchased (120 days), 
median (iQr)/mean (sD)b
6 (4–9)/6.5 (3.8) 6 (3–9)/6.3 (3.9)
0, n (%) 1,621 (3.5) 1,235 (4.5)
1–4, n (%) 13,749 (29.4) 8,693 (31.3)
5–9, n (%) 21,302 (45.5) 11,956 (43.0)
≥10, n (%) 9,480 (20.3) 5,358 (19.3)
Missing, n (%) 671 (1.4) 538 (1.9)
Prior hospital admission (1 year), 
median (iQr)/mean (sD)c
0 (0–1)/0.9 (1.4) 1 (0–2)/1.1 (1.7)
0, n (%) 25,930 (55.4) 13,763 (49.5)
1–2, n (%) 16,479 (35.2) 10,176 (36.6)
≥3, n (%) 4,413 (9.4) 3,841 (13.8)
Missing, n (%) 1 (0.0) 0 (0.0)
Notes: aThe CCi was calculated based on hospital discharge diagnoses during 10 years before baseline. ball redeemed prescriptions were included, except from the following 
aTC codes: B05x (blood substitutes and perfusion solutions), B06x (other hematological agents), D09x (medicated dressings), J07x (vaccines), n01x (anesthetics), and Vx 
(various); medications were counted at the fourth level of the ATC code, ie, including the first five digits of the ATC code (eg, salicylic acid and derivates: N02BA). cBased 
on hospital admissions during 1 year before baseline. normal distributed data are presented with mean (sD), whereas non-normal distributed data are presented with both 
median (iQr) and mean (sD).
Abbreviations: aTC, anatomical Therapeutic Chemical; Bi, Barthel index; BMi, body mass index; CCi, Charlson comorbidity index.
3 and 4). The risk of overall mortality (HR [95% CI]) was 
increased, 2.41 (2.31–2.51) in women and 2.07 (1.97–2.18) 
in men, for subcategory “BI =0–24” compared with “BI =80–
100” as the reference category (Table 3). BI was associated 
with both increased short- and long-term mortality with the 
corresponding 7-day, 30-day, 90-day, 1-year, and 2-year risk 
of mortality for women, (HR [95% CI]) 14.61 (8.47–25.19), 
8.64 (7.11–10.49), 5.59 (5.01–6.25), 3.83 (3.57–4.10), and 
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1.00
0.75
0.50
0.25
0.00
0 1 2 3 4 5
Analysis time (years)
Kaplan–Meier survival estimates
Total population, n=69,935
 15804 13256 10029 7537 5435 3825 2497 1637 1087 599 219
 22508 16844 12140 8548 5849 3760 2327 1450 863 433 149
 16478 11067 7743 5160 3296 2017 1183 722 429 210 76
 15145 7766 5153 3169 1939 1120 641 350 200 83 22
 9970   8643 6740 5154 3813 2750 1846 1230 830 461 172
 14683 11436 8517 6150 4279 2830 1784 1118 686 348 132
 10374 7375 5316 3656 2365 1479 883 540 327 164 56
 8967   4804 3252 2008 1247 737 423 226 131 60 19
 5834 4613 3289 2383 1622 1075 651 407 257 138 47
 7825 5408 3623 2398 1570 930 543 332 177 85 17
 6104 3692 2427 1504 931 538 300 182 102 46 20
 6178 2962 1901 1161 692 383 218 124 69 23 3
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
Number at risk
6 7 8 9 10 11
1.00
0.75
0.50
0.25
0.00
0 1 2 3 4 5
Analysis time (years)
Kaplan–Meier survival estimates
Women, n=43,994
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
Number at risk
6 7 8 9 10 11
1.00
0.75
0.50
0.25
0.00
0 1 2 3 4 5
Analysis time (years)
Kaplan–Meier survival estimates
Men, n=25,941
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
BI: 80–100
Bl: 50–79
Bl: 25–49
Bl: 0–24
Number at risk
6 7 8 9 10 11
Figure 2 Survival for the total cohort stratified by gender: for each of the four predefined BI subcategories (0–24, 25–49, 50–79, 80–100).
Abbreviation: Bi, Barthel index.
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3.10 (2.93–3.28), and for men, 9.37 (5.68–15.46), 5.14 
(4.30–6.14), 3.89 (3.48–4.35), 2.77 (2.57–2.98), and 2.44 
(2.29–2.60) for subcategory “BI =0–24” compared with “BI 
=80–100” as the reference category (Table 4).
Two variables were exposed to a substantial amount of 
missing data: the BI and the BMI. Among patients without 
a BI score (n=4,635) more were men (39.3% vs 37.1%); 
they were slightly younger, were more often married, and 
had more comorbidity compared with patients with a BI 
score. Furthermore, patients without a BI score had a lower 
crude survival compared with patients with a BI score (data 
not shown).
In terms of BMI, the additional analysis revealed that 
patients with missing BMI data (n=15,698, and of these 
patients n=12,417 had a BI score) had lower BI, more 
comorbidities, and more prior hospitalizations compared 
with patients with a BMI score. Furthermore, patients with 
Table 2 Univariable hrs and corresponding 95% Cis for overall 
mortality by gender
Exposure Women
HR (95% CI)
Men
HR (95% CI)
Bi
80–100 1 (reference) 1 (reference)
50–79 1.42 (1.38–1.47) 1.40 (1.35–1.46)
25–49 1.76 (1.70–1.82) 1.73 (1.66–1.81)
0–24 2.72 (2.62–2.82) 2.29 (2.19–2.39)
age group (years)
65–74 1 (reference) 1 (reference)
75–84 1.38 (1.33–1.44) 1.51 (1.45–1.57)
85–94 2.07 (1.99–2.16) 2.26 (2.17–2.35)
≥95 3.30 (3.12–3.50) 3.25 (2.98–3.55)
Period of admission
2005–2009 1 (reference) 1 (reference)
2010–2014 1.02 (0.99–1.04) 1.01 (0.99–1.04)
CCia
0 1 (reference) 1 (reference)
1–2 1.44 (1.39–1.49) 1.28 (1.21–1.35)
≥3 2.14 (2.06–2.21) 1.86 (1.76–1.96)
Medications at 
admissionb
0 1 (reference) 1 (reference)
1–4 1.08 (1.01–1.15) 1.21 (1.13–1.30)
5–9 1.25 (1.18–1.34) 1.44 (1.34–1.54)
≥10 1.39 (1.29–1.50) 1.60 (1.47–1.74)
Prior (1 year) 
hospital admissionc
0 1 (reference) 1 (reference)
1–2 1.15 (1.12–1.17) 1.17 (1.14–1.21)
≥3 1.34 (1.29–1.39) 1.49 (1.43–1.55)
Notes: aThe CCi was calculated based on hospital discharge diagnoses during 10 
years before baseline. ball redeemed prescriptions were included, except from 
the following aTC codes: B05x (blood substitutes and perfusion solutions), B06x 
(other hematological agents), D09x (medicated dressings), J07x (vaccines), n01x 
(anesthetics), and Vx (various); medications were counted at the fourth level of the 
ATC code, ie, including the first five digits of the ATC code (eg, salicylic acid and 
derivates: n02Ba). cBased on hospital admissions during 1 year before baseline.
Abbreviations: aTC, anatomical Therapeutic Chemical; Bi, Barthel index; CCi, 
Charlson comorbidity index.
Table 3 Multivariable hrs and corresponding 95% Cis for overall 
mortality according to the Bi by gender, using the subcategory 
“Bi=80–100” as the reference category
Women
HR (95% CI)a
Men
HR (95% CI)a
Overall mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 1.34 (1.29–1.39) 1.29 (1.23–1.35)
Bi 25–49 1.66 (1.60–1.73) 1.58 (1.51–1.66)
Bi 0–24 2.41 (2.31–2.51) 2.07 (1.97–2.18)
Notes: aadjusted for age group, marital status, BMi, CCi, number of different 
medications purchased in the 120 days prior to index date, number of hospital 
admissions during 1 year before baseline, and period of index admission. Women: 
n=35,818; men: n=20,754.
Abbreviations: Bi, Barthel index; BMi, body mass index; CCi, Charlson 
comorbidity index.
Table 4 Multivariable hrs and corresponding 95% Cis for 7-day, 
30-day, 90-day, 1-year, and 2-year mortality according to the Bi 
by gender, using the subcategory “Bi=80–100” as the reference 
category
Women
HR (95% CI)a
Men
HR (95% CI)a
7-day mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 2.77 (1.55–4.95) 1.90 (1.10–3.30)
Bi 25–49 4.44 (2.51–7.89) 3.22 (1.89–5.49)
Bi 0–24 14.61 (8.47–25.19) 9.37 (5.68–15.46)
30-day mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 2.19 (1.78–2.69) 1.62 (1.34–1.97)
Bi 25–49 3.49 (2.84–4.27) 2.35 (1.94–2.84)
Bi 0–24 8.64 (7.11–10.49) 5.14 (4.30–6.14)
90-day mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 1.83 (1.63–2.05) 1.61 (1.44–1.81)
Bi 25–49 2.73 (2.44–3.06) 2.22 (1.98–2.49)
Bi 0–24 5.59 (5.01–6.25) 3.89 (3.48–4.35)
1-year mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 1.60 (1.49–1.72) 1.40 (1.29–1.50)
Bi 25–49 2.19 (2.04–2.35) 1.89 (1.75–2.04)
Bi 0–24 3.83 (3.57–4.10) 2.77 (2.57–2.98)
2-year mortality
Bi 80–100 1 (reference) 1 (reference)
Bi 50–79 1.49 (1.41–1.57) 1.38 (1.30–1.47)
Bi 25–49 1.92 (1.82–2.04) 1.76 (1.65–1.87)
Bi 0–24 3.10 (2.93–3.28) 2.44 (2.29–2.60)
Notes: aadjusted for age group, marital status, BMi, CCi, number of different 
medications purchased in the 120 days prior to index date, number of hospital 
admissions during 1 year before baseline, and period of index admission. Women: 
n=35,818; men: n=20,754.
Abbreviations: Bi, Barthel index; BMi, body mass index; CCi, Charlson 
comorbidity index.
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missing data on BMI had a lower crude survival compared 
with patients with complete data on BMI. Nevertheless, the 
crude association between the BI and mortality was similar 
in the missing vs the non-missing BMI population, ie, the 
lower the BI score the higher the mortality (data not shown).
Discussion
In our study, the BI-100 was found to be associated with 
overall, short- and long-term mortality in hospitalized geri-
atric patients (both women and men) even in the multivari-
able model. Lower scores on the BI were associated with 
increased mortality.
Strengths and limitations
Our study has several strengths. To the best of our knowledge, 
this is the first study to assess the association between BI and 
mortality in hospitalized geriatric patients using nationwide 
data in a longitudinal cohort design with a long follow-up 
of 11 years. We were able to perform accurate linkage at the 
individual level between the nationwide population-based 
Danish health registers28–30 and the Danish NDG.23 The link-
age of register data allowed us to account for all patients dur-
ing the entire study period with no patients lost to follow-up, 
thereby increasing the validity of our results.
The study also has limitations. First, the geriatric database 
has a completeness of 90%, which might limit the possibili-
ties of extrapolating the results to other populations. Yet, the 
database completeness reaches the standard requirement for 
national clinical databases.23 Second, when adjusting for prior 
medications, we were not able to account for over-the-counter 
drugs or the actual adherence to the prescribed medication. 
This may have led to under- or overestimation of the impact 
of number of medications at admission. Third, according to 
NDG guidelines, BI score should be evaluated within 24 
hours of admission to the geriatric department. However, we 
had no information on the actual timing of the BI scoring 
in the database, which may have introduced a potential bias 
concerning misclassification. But we assume that the risk 
of misclassification of patients into BI subcategories would 
be evenly distributed in the cohort. Fourth, even though we 
accounted for several confounders we had no data available 
on socioeconomic position or lifestyle factors such as smok-
ing or alcohol use. Fifth, when we accounted for comorbidity, 
we calculated CCI using prior ICD-10 diagnoses from the 
health registers. This may have introduced information bias, 
because these data are based on hospital discharge records. 
However, a prior study has shown high validity in using the 
Danish National Registers to calculate CCI.41 Finally, some 
patients had missing data on BI (6.2%). Among patients 
with missing data on BI the proportion of men were higher, 
patients were younger, and had more comorbidity. However, 
the observed differences were very small and most likely due 
to the large sample size. A substantially higher proportion 
had missing data on the BMI variable (21.0%). Less than 
10% of missing data may not be critical to the results of a 
study,39 but the relatively high proportion of patients with 
missing data on BMI may have introduced selection bias 
in our study. The results of the additional analysis revealed 
that the patients with missing BMI were more disabled and 
had worse health and survival compared with patients with 
complete data on BMI. Thus, we excluded the disabled and 
diseased patients from the multivariable analyses. However, 
the association between BI and mortality was found to be 
similar in the missing and non-missing BMI population, ie, 
the lower the BI score the higher the mortality. This may 
indicate that selection bias cannot account for the pronounced 
association as revealed between the BI and mortality using 
complete case analysis. Rather, the fully adjusted estimates 
may be too conservative, because we excluded a high pro-
portion of diseased patients with low BI and high mortality 
from the multivariable models.
In the present study, we categorized BI into four standard 
subcategories established by the Danish health authorities 
for administrative purposes.33 An earlier and smaller single-
center Danish study using a shorter time period employed the 
same BI subcategories.27 The study reported slightly lower 
median survival for each BI subcategory, but their overall 
results corroborate our findings. The difference between the 
two studies might be due to the possible overestimation of 
the influence of BI on mortality in the prior study27 since 
no data on BMI or medications were available. Other stud-
ies that address the association between ADL and risk of 
mortality also corroborate our findings, notwithstanding the 
choice of BI cutoff level,42–44 whether they are community-
dwellers24,25,45 or institutionalized,46 whether BI is assessed 
at admission or at discharge,47 or whether disease-specific 
populations are addressed (hip fracture,48 dementia,49 pneu-
monia,42 heart failure,50 or non-valvular atrial fibrillation43).
All these previous studies show the same trend as our study, 
ie, reduced ADL is associated with increased risk of mortal-
ity which advocates for the importance of addressing older 
people’s functional capacity at hospital admission.
When addressing the future challenges with a growing 
population of older patients with multimorbidity and multiple 
disabilities,1,11 it would be desirable to be able to include 
the level of dependency in ADL in the overall assessment 
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of patients for the purpose of evaluating future health care 
resources. Furthermore, the information on dependency is of 
great importance in the conversation with patients and their 
relatives regarding the level of future medical diagnostics and 
treatment as well as care plans. Many prognostic indices exist, 
but are time-consuming,17 do not take the actual dependency 
into account,15,16,51 or use data that are not intuitively the 
most relevant to health care professionals.51 BI is a simple 
measure, easy to interpret in clinical practice, takes around 5 
minutes for a nurse/nursing assistant to carry out,19 and has 
a high reliability.19,32
Our data do not allow for the prediction of mortality at 
the individual level, but can provide a probability. Specific 
categories of patients at risk were identified. We found more 
disability in men in terms of lower BI and also a higher mortal-
ity. In general, men tend to have higher mortality but have fewer 
disabilities than women.52 The reason for this is still debated 
and not fully understood. However, some data suggest that men 
may react later to severe symptoms than women and are there-
fore more likely to be hospitalized at more advanced stages of 
disease and thus at a greater risk of dying.53 This could be the 
case in our study and at least partly explain why we see more 
disability in this hospital sample of acutely admitted older men. 
Our study also revealed that the association of BI with mortal-
ity is strongest for those patients in the lowest subcategory and 
especially high on the very short-term mortality. This is evident 
across gender but especially for women (7 days, 14.61 [95% CI 
8.47–25.19]). This information is of particular importance for 
clinicians allowing useful supplementary knowledge to help 
identify patients at high risk and to support clinical decision 
making. BI should thus not be used as a definite prognostic 
instrument but rather as an add-on to the indicators physicians 
use in daily clinical practice.
Future perspectives of our results could be addressing the 
use of BI both at admission and at discharge from hospital 
to understand the impact of potential changes in BI during 
hospitalization. BI could also be routinely assessed in the pri-
mary health care system, as a recent Danish study has shown 
a significant increase in home care prior to acute hospital 
admission.54 This way, information on changes from prior to 
actual functional level might be used to identify older people 
at risk of admission as well as a useful information when tar-
geting treatment and rehabilitation of the individual patient.
Conclusion
ADL assessed by BI at the time of admission to a geriatric 
hospital department is associated with overall, short, and 
long-term mortality in both genders also in the multivariable 
model. BI has the potential to provide useful supplementary 
information for the planning of treatment and future care 
of older patients. Future studies are needed to look further 
into the ADL phenotypes of those patients with the highest 
mortality, to explore which domain in the BI has the highest 
impact, and to investigate whether improving level of func-
tioning might improve survival.
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